title: Pregnancy in cystic fibrosis.
abstract: The challenges posed by cystic fibrosis (CF), including poor nutrition and progressive lung function decline, may pose problems for pregnancy for both mother and child. A multidisciplinary team of providers is optimal to help address the variety of issues that might arise in such a pregnancy. Careful attention to maternal weight gain, pulmonary function and exacerbations, and screening for gestational diabetes is necessary. Pregnancies among women with CF are associated with more frequent use of intravenous antibiotics and hospitalization than is seen in nonpregnant CF women. This article reviews maternal and fetal outcomes for CF in pregnancy.
authors.affiliation: Section of Pulmonary & Critical Care Medicine, Yale University School of Medicine, 333 Cedar Street, PO Box 208057, New Haven, CT 06520-8057, USA. Electronic address: j.mcardle@cox.net.
authors.forename: John R
authors.initials: JR
authors.lastname: McArdle
mesh_terms: D003550:Cystic Fibrosis / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D036861:Delivery, Obstetric; D016640:Diabetes, Gestational / Q000209:etiology; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005298:Fertility / Q000502:physiology; D005541:Forced Expiratory Volume; D005820:Genetic Testing; D006801:Humans; D008168:Lung / Q000503:physiopathology; D016040:Lung Transplantation; D044342:Malnutrition / Q000209:etiology; D008428:Maternal Mortality; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D011256:Pregnancy Outcome; D013723:Teratogens
chemical_list: D013723:Teratogens